האיחוד האירופי - פינית - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - chondrogenic aiheuttama hevosen allogeenista perifeerisen veren-johdettu mesenkymaaliset kantasolut - muut lääkkeet liikuntaelinten sairauksien häiriöihin - hevoset - vähentäminen on lievä tai kohtalainen toistuvaa ontumista, jotka liittyvät ei-septinen niveltulehdus hevosilla.

האיחוד האירופי - פינית - EMA (European Medicines Agency)

bayer animal health gmbh - iron(iii) ion, toltrazuril - toltratsuriili, yhdistelmiä - siat (porsaat) - sillä samanaikainen ehkäisy kokkidioosin kliinisten oireiden (kuten ripuli) vastasyntyneiden porsaiden maatiloilla, joilla on vahvistettu historia kokkidioosin aiheuttamaa cystoisospora suis, ja ehkäisyyn raudanpuute anemia.

האיחוד האירופי - פינית - EMA (European Medicines Agency)

laboratorios hipra s.a. - eläviä, heikennettyjä naudan hengityselinten rs-viruksen (brsv), kanta lym-56 - immunologisia valmisteita varten bovidae, karjaa, elävät virusrokotteet, naudan hengityselinten rs-viruksen (brsv) - karja - aktiivinen immunisaatio nautojen vähentää viruksen leviämistä ja hengityselinten kliinisten oireiden aiheuttama naudan hengityselinten rs-virus infektio.

האיחוד האירופי - פינית - EMA (European Medicines Agency)

qbiotics netherlands b.v. - tigilanol tiglate - tigilanol tiglate - koirat - hoitoon ei-resectable non-metastaattinen (joka lavastus) ihon alle mast-solu kasvain sijaitsee tai distaalinen kyynärpää tai hock, ja ei-resectable non metastasoitunut ihon mast-solujen kasvaimia koirilla.

האיחוד האירופי - פינית - EMA (European Medicines Agency)

ceva-phylaxia co. ltd. - live recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus (rfp-lt) and avian encephalomyelitis virus, strain calnek 1143 (ae) - immunologicals for aves, live viral vaccines, domestic fowl - kana - for active immunisation of chickens of 8 to 13 weeks of age in order to reduce the skin lesions due to fowlpox, to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis and to prevent egg production losses due to avian encephalomyelitis.

האיחוד האירופי - פינית - EMA (European Medicines Agency)

laboratorios hipra, s.a. - mycoplasma hyopneumoniae, strain 7304 (nexhyon), expressing the capsid protein of porcine circovirus type 2a, inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - siat - for the active immunisation of pigs:to reduce lung lesions associated with porcine enzootic pneumonia caused by mycoplasma hyopneumoniae. also, to reduce the incidence of these lesions (as observed in field studies). to reduce viraemia, virus load in lungs and lymphoid tissues and the duration of the viraemic period associated with diseases caused by porcine circovirus type 2 (pcv2). efficacy against pcv2 genotypes a, b and d has been demonstrated in field studies. to reduce culling rate and the loss of daily weight gain caused by mycoplasma hyopneumoniae and/or pcv2 related diseases (as observed at 6 months of age in field studies). mycoplasma hyopneumoniae: onset of immunity: 3 weeks after vaccinationduration of immunity: 23 weeks after vaccinationporcine circovirus type 2:onset of immunity: 2 weeks after vaccinationduration of immunity: 22 weeks after vaccinationin addition, a reduction in nasal and faecal shedding and the duration of nasal excretion of pcv2 was demonstrated in animals challenged at 4 weeks and at 22 weeks after vaccination.

האיחוד האירופי - פינית - EMA (European Medicines Agency)

zoetis belgium - bedinvetmab - kipulääkkeet - koirat - for the alleviation of pain associated with osteoarthritis in dogs.

האיחוד האירופי - פינית - EMA (European Medicines Agency)

zoetis belgium sa - frunevetmab - kipulääkkeet - kissat - for the alleviation of pain associated with osteoarthritis in cats.

האיחוד האירופי - פינית - EMA (European Medicines Agency)

ceva-phylaxia co. ltd. - recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live - kana - for active immunisation of chickens from 8 weeks of age in order to reduce the skin lesions due to fowlpox and to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis.

האיחוד האירופי - פינית - EMA (European Medicines Agency)

intervacc ab - recombinant streptococcus equi protein cce, recombinant streptococcus equi protein eq85, recombinant streptococcus equi protein idee - hevoseläinten immunologiset - hevoset - for the active immunisation to reduce clinical signs and the number of abscesses in acute stage of infection with s. equi.